Vaccinia virus subverts xenophagy through phosphorylation and nuclear targeting of p62

Melanie Krause, Jerzy Samolej, Artur Yakimovich, János Kriston-Vizi, Moona Huttunen, Samuel Lara‐Reyna, Eva‐Maria Frickel, Jason MercerThe Journal of Cell Biology 2024 · DOI

TL;DR

Vaccinia virus (VACV), a cytoplasmic pathogen, actively evades the cell's autophagy-based defense system (xenophagy). It achieves this by hijacking the host protein p62, phosphorylating it via viral kinases, and shunting it to the nucleus, thereby preventing p62 from targeting and degrading the virus.

What Problem Does This Paper Address?

Autophagy is a cellular process that degrades unwanted or damaged components, including invading pathogens (xenophagy). While it's known that viruses often manipulate autophagy, how poxviruses, which replicate entirely in the cytoplasm, deal with this defense mechanism is less understood. This paper investigates how vaccinia virus (VACV), a prototypic poxvirus, circumvents xenophagy, specifically focusing on the role of autophagy receptors like p62.

Methods

The researchers employed a multi-pronged approach:

  • Overexpression studies: They overexpressed key autophagy receptors (p62, NDP52, Tax1Bp1, NBR1, OPTN) in cells and then infected them with VACV to see which receptors could restrict viral production.
  • Immunoblotting and Immunofluorescence (IF): These techniques were used to track the levels and localization of autophagy receptors and viral components during infection.
  • Mutagenesis: They created mutant versions of p62, specifically altering its nuclear localization signals (NLS1 and NLS2), to understand which parts of p62 were crucial for its VACV-induced nuclear translocation.
  • Kinase inhibition and depletion: They used chemical inhibitors (BIRB796 for p38 MAPK) and siRNA to deplete specific cellular (p38) and viral (B1, F10) kinases to determine their role in p62 phosphorylation and nuclear translocation.
  • Live-cell imaging: This allowed them to observe the dynamic process of p62 localization and its interaction with incoming VACV virions in real-time.
  • Nuclear/cytoplasmic fractionation: This biochemical method separated cellular components to precisely quantify the distribution of p62 in different cellular compartments.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • VACV plays a multi-layered defense: The virus doesn't just have one trick; it uses different strategies to neutralize different autophagy receptors.
  • p62 is a key target, but not degraded: Unlike other receptors like NDP52 and Tax1Bp1, which VACV degrades, p62 is actively moved out of the way.
  • Nuclear shunting is the strategy for p62: VACV forces p62 into the nucleus, effectively removing it from the cytoplasm where the virus resides and replicates.
  • Viral kinases are the "pushers": Specific VACV-encoded kinases (B1 and F10) are responsible for phosphorylating p62, which is the trigger for its nuclear translocation.
  • NLS2 is the "door" to the nucleus: The nuclear localization signal 2 (NLS2) on p62 is essential for this VACV-mediated nuclear movement.

Key Results

  • Overexpression of p62, NDP52, and Tax1Bp1 significantly restricted VACV production (75-92%).
  • During VACV infection, NDP52 and Tax1Bp1 were degraded, while p62 levels remained stable but its localization shifted dramatically from the cytoplasm to the nucleus.
  • This nuclear translocation of p62 was dependent on its NLS2 domain.
  • VACV infection led to increased phosphorylation of p62 at T269/S272, a modification linked to NLS2 activity.
  • This phosphorylation and subsequent nuclear translocation were dependent on VACV-encoded kinases B1 and F10, but not the host p38 MAPK.
  • Mutating p62's NLS2 domain prevented its nuclear translocation and led to a more significant reduction in viral yield when overexpressed, suggesting cytoplasmic p62 can still interfere with viral replication.

Limitations and Future Work

  • Specific viral proteins: While early viral genes were implicated in initiating p62 nuclear translocation, the specific early protein(s) responsible were not identified.
  • Mechanism of phosphorylation: The precise mechanism by which B1 and F10 kinases phosphorylate p62 and how this leads to NLS2 activation requires further investigation.
  • Pro-viral role of nuclear p62: The paper notes recent findings suggesting nuclear p62's role in suppressing stress-induced apoptosis and its potential relevance to NFkB regulation by VACV. Future work could explore if nuclear p62 has a pro-viral role during poxvirus infection.
  • Broader implications: The study suggests a more general role for viral kinases in immune modulation beyond just p62 regulation, which warrants further exploration.

Summary updated

Abstract

Autophagy is an essential degradation program required for cell homeostasis. Among its functions is the engulfment and destruction of cytosolic pathogens, termed xenophagy. Not surprisingly, many pathogens use various strategies to circumvent or co-opt autophagic degradation. For poxviruses, it is known that infection activates autophagy, which however is not required for successful replication. Even though these complex viruses replicate exclusively in the cytoplasm, autophagy-mediated control of poxvirus infection has not been extensively explored. Using the prototypic poxvirus, vaccinia virus (VACV), we show that overexpression of the xenophagy receptors p62, NDP52, and Tax1Bp1 restricts poxvirus infection. While NDP52 and Tax1Bp1 were degraded, p62 initially targeted cytoplasmic virions before being shunted to the nucleus. Nuclear translocation of p62 was dependent upon p62 NLS2 and correlated with VACV kinase mediated phosphorylation of p62 T269/S272. This suggests that VACV targets p62 during the early stages of infection to avoid destruction and further implies that poxviruses exhibit multi-layered control of autophagy to facilitate cytoplasmic replication.
BibTeX
@article{krause2024vaccinia,
  author = {Melanie Krause and Jerzy Samolej and Artur Yakimovich and János Kriston-Vizi and Moona Huttunen and Samuel Lara‐Reyna and Eva‐Maria Frickel and Jason Mercer},
  title = {{Vaccinia virus subverts xenophagy through phosphorylation and nuclear targeting of p62}},
  journal = {The Journal of Cell Biology},
  year = {2024},
  doi = {10.1083/jcb.202104129},
}
Figure